Literature DB >> 21406130

Febrile seizures.

Leena D Mewasingh1.   

Abstract

INTRODUCTION: Simple febrile seizures are generalised in onset, last <15 minutes, and do not occur more than once in 24 hours. Complex febrile seizures are longer lasting, have focal symptoms, and can recur within 24 hours. This review only deals with simple febrile seizures. About 2% to 5% of children in the USA and Western Europe, and 6% to 9% of infants and children in Japan will have experienced at least one febrile seizure by the age of 5 years. Simple febrile seizures may slightly increase the risk of developing epilepsy, but have no known adverse effects on behaviour, scholastic performance, or neurocognition. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments given during episodes of fever in children with one or more previous simple febrile seizures? What are the effects of long-term (daily, for >1 month) anticonvulsant treatment in children with a history of simple febrile seizures? What are the effects of treatments on reducing the risk of subsequent epilepsy in children with a history of simple febrile seizures? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 18 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: anticonvulsants (intermittent or continuous) and antipyretic treatments (physical antipyretic measures, paracetamol, ibuprofen).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21406130      PMCID: PMC3275324     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  40 in total

1.  Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.

Authors:  N R Temkin
Journal:  Epilepsia       Date:  2001-04       Impact factor: 5.864

2.  Seizure risk in offspring of individuals with a history of febrile convulsions.

Authors:  H Doose; A Maurer
Journal:  Eur J Pediatr       Date:  1997-06       Impact factor: 3.183

3.  Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest.

Authors:  E W Johnson; J Dubovsky; S S Rich; C A O'Donovan; H T Orr; V E Anderson; A Gil-Nagel; P Ahmann; C G Dokken; D T Schneider; J L Weber
Journal:  Hum Mol Genet       Date:  1998-01       Impact factor: 6.150

Review 4.  Febrile seizures--treatment and outcome.

Authors:  F U Knudsen
Journal:  Brain Dev       Date:  1996 Nov-Dec       Impact factor: 1.961

5.  Unprovoked seizures in children with febrile seizures: short-term outcome.

Authors:  A T Berg; S Shinnar
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

Review 6.  Hematologic toxicity of sodium valproate.

Authors:  S Acharya; J B Bussel
Journal:  J Pediatr Hematol Oncol       Date:  2000 Jan-Feb       Impact factor: 1.289

7.  Long term outcome of prophylaxis for febrile convulsions.

Authors:  F U Knudsen; A Paerregaard; R Andersen; J Andresen
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

8.  Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

9.  Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies.

Authors:  M Offringa; P M Bossuyt; J Lubsen; J H Ellenberg; K B Nelson; F U Knudsen; J F Annegers; A S el-Radhi; J D Habbema; G Derksen-Lubsen
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

10.  Role of phenobarbitone in preventing recurrence of febrile convulsions.

Authors:  N Thilothammal; P V Krishnamurthy; K G Kamala; S Ahamed; K Banu
Journal:  Indian Pediatr       Date:  1993-05       Impact factor: 1.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.